Wealth Enhancement Trust Services’s Ironwood Pharmaceuticals IRWD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
– Sell
-119
Closed -$501 – 1139
2026
Q2
$501 Buy
+119
New +$459 ﹤0.01% 1243

Other funds holding IRWD

Wealth Enhancement Trust Services's IRWD Position: Q3 2026 in Review

Wealth Enhancement Trust Services sold out of Ironwood Pharmaceuticals (IRWD) in Q3 2026, closing a stake of 119 shares — an estimated $501 sold.

Wealth Enhancement Trust Services first reported a position in IRWD in Q2 2026 and held it in 1 quarter. The position peaked at $501 in Q2 2026. 176 funds tracked by Wall St. Rank hold IRWD as of Q3 2026.

  • Wealth Enhancement Trust Services reported no remaining Ironwood Pharmaceuticals position as of Q3 2026 after selling out during the quarter.
  • Wealth Enhancement Trust Services sold 119 Ironwood Pharmaceuticals shares in Q3 2026, an estimated $501.
  • Wealth Enhancement Trust Services first reported a position in Ironwood Pharmaceuticals in Q2 2026 and held it in 1 quarter.
  • Wealth Enhancement Trust Services's Ironwood Pharmaceuticals position peaked at $501 in Q2 2026.
  • 176 funds tracked by Wall St. Rank held Ironwood Pharmaceuticals as of Q3 2026.

Based on Wealth Enhancement Trust Services's 13F filing for Q3 2026, filed 7 Oct 2026.